NIOX Group (LON:NIOX) Stock Price Down 3.3% – Here’s What Happened

NIOX Group Plc (LON:NIOX) was down 3.3% during trading on Tuesday . The company traded as low as GBX 69.40 ($0.93) and last traded at GBX 69.60 ($0.93). Approximately 604,782 shares changed hands during trading, a decline of 43% from the average daily volume of 1,053,004 shares. The stock had previously closed at GBX 72 ($0.96).

NIOX Group Stock Performance

The stock has a market capitalization of £300.87 million, a P/E ratio of 57.60 and a beta of 0.92. The firm has a 50-day moving average of GBX 72.30 and a 200 day moving average of GBX 68.66. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.

NIOX Group (LON:NIOX) last posted its quarterly earnings data on Tuesday, September 30th. The company reported GBX 1.43 EPS for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. Research analysts anticipate that NIOX Group Plc will post 1.1658256 EPS for the current fiscal year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.